{"filing":{"accession_number":"0001493152-26-027266","cik":"0001535955","ticker":"LPCN","company_name":"Lipocine Inc.","form":"8-K","filing_date":"2026-06-04","report_date":null,"primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315226027266/form8-k.htm"},"events":[{"id":6923,"run_id":6069,"accession_number":"0001493152-26-027266","anchor_item_number":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"The filing discloses results of Lipocine's June 3, 2026 annual shareholder meeting under Item 5.07, including voting outcomes on director elections, auditor ratification, executive compensation advisory vote, and approval of the Sixth Amended and Restated 2014 Stock and Incentive Plan with increased share authorization (from 600,000 to 1,000,000 shares) and individual award limits (from 25,000 to 100,000). The shareholder approval of the expanded equity plan is material to investors assessing potential dilution and executive compensation arrangements.","company_name":"Lipocine Inc.","ticker":"LPCN","filing_date":"2026-06-04","form":"8-K","submitted_at":null,"items":null}],"classifications":[{"id":4475,"accession_number":"0001493152-26-027266","item_number":null,"item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses results of Lipocine's June 3, 2026 annual shareholder meeting under Item 5.07, including voting outcomes on director elections, auditor ratification, executive compensation advisory vote, and approval of the Sixth Amended and Restated 2014 Stock and Incentive Plan with increased share authorization (from 600,000 to 1,000,000 shares) and individual award limits (from 25,000 to 100,000). The shareholder approval of the expanded equity plan is material to investors assessing potential dilution and executive compensation arrangements.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-05T05:21:57.313038+00:00","company_name":"Lipocine Inc.","ticker":"LPCN","filing_date":"2026-06-04"}]}